Keywords: Alzheimer's Disease, Alzheimer's DiseaseAlzheimer's disease (AD) resemblance atrophy index (AD-RAI) is a novel MRI-based machine-learning derived imaging biomarker for AD that is valid in detection of early AD. We selected 318 CU and MCI subjects in ADNI with four-year follow-up with 1471 serial MRI scans to assess longitudinal changes of the MRI biomarkers (i.e., AD-RAI, HV, HF, BPV, BPF) in correlation with the change in time and conversion status. We used generalized linear mixed-effects models to compute and show the predictive value. AD-RAI over time showed the highest classification accuracy for predicting converters when compared with other imaging biomarkers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords